P-76 A phase 1 study of AMG 199, a half-life extended...

Annals of Oncology 2020 / 07 Vol. 31

P-76 A phase 1 study of AMG 199, a half-life extended bispecific T-cell engager (HLE BiTE®) immune therapy, targeting MUC17 in patients with gastric and gastroesophageal junction cancer

Lordick, F., Orra, E. Buxó, Cervantes, A., Dayyani, F., Rocha-Lima, C., Greil, R., Laarhoven, H. van, Lorenzen, S., Kischel, R., Shitara, K., Chao, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.04.158
Date:
July, 2020
File:
PDF, 88 KB
2020
Conversion to is in progress
Conversion to is failed